A phase 2 asthma study of Upstream Bio’s TSLP receptor agonist has hit its primary endpoint. But with only the 12-week ...

Olema Pharmaceuticals, Inc. ( OLMA) Citi's 2026 Virtual Oncology Leadership Summit February 19, 2026 1:00 PM EST ...

A recent study has revealed how the psychedelic brew ayahuasca alters brain waves to induce profound mystical experiences and ...

The U.S. Food and Drug Administration approved Cobenfy on September 26, 2024, making it the first schizophrenia drug with a fundamentally new mechanism of action in more than half a century. Built on ...

Your base sets the mood for every session, and on shared worlds the whole experience often comes down to reliable hosting for ...

Many of us an impulse and a deep down desire to write something and project it to the world. Whether it is a long novel, a screenplay for a motion picture, a short story , poems or any piece of ...

Some say we’ve entered a new age of AI-enabled scientific discovery. But human insight and creativity still can’t be ...

A big change is on its way that will mean some homes will be blocked from streaming content online. The alert has been raised for UK homes that use BT TV, as certain set-top boxes are losing support ...

Looking ahead to upcoming milestones, we expect to report phase one data for o five eight in the second half of this year, ...

Sanofi and Teva’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease In the RELIEVE UCCD LTE phase 2b study, duvakitug ...

This study provides a useful contribution to understanding how wearable augmentation devices interact with human proprioception, using a longitudinal design over a single session. Results demonstrate ...

Background Motor and cognitive dysfunctions are common and disabling features in multiple sclerosis (MS) that remain challenging to treat. Here, we aimed to explore the effect of exergames as a ...